(4R)-4-[3-[3-[4-[3-(methylsulfonylmethyl)azetidin-1-yl]phenyl]azetidin-1-yl]-3-oxopropyl]-1,3-oxazolidin-2-one

C20H27N3O5S — CID 162745804

IUPAC(4R)-4-[3-[3-[4-[3-(methylsulfonylmethyl)azetidin-1-yl]phenyl]azetidin-1-yl]-3-oxopropyl]-1,3-oxazolidin-2-one
SMILESCS(=O)(=O)CC1CN(c2ccc(C3CN(C(=O)CC[C@@H]4COC(=O)N4)C3)cc2)C1
InChIInChI=1S/C20H27N3O5S/c1-29(26,27)13-14-8-22(9-14)18-5-2-15(3-6-18)16-10-23(11-16)19(24)7-4-17-12-28-20(25)21-17/h2-3,5-6,14,16-17H,4,7-13H2,1H3,(H,21,25)/t17-/m1/s1
InChIKeyXSAGVSKRGAPOAD-QGZVFWFLSA-N
MW421.52 g/mol
LogP0.98
Rot. Bonds7

About (4R)-4-[3-[3-[4-[3-(methylsulfonylmethyl)azetidin-1-yl]phenyl]azetidin-1-yl]-3-oxopropyl]-1,3-oxazolidin-2-one

(4R)-4-[3-[3-[4-[3-(methylsulfonylmethyl)azetidin-1-yl]phenyl]azetidin-1-yl]-3-oxopropyl]-1,3-oxazolidin-2-one (PubChem CID 162745804) has the molecular formula C20H27N3O5S and a molecular weight of 421.52 g/mol. Its IUPAC name is (4R)-4-[3-[3-[4-[3-(methylsulfonylmethyl)azetidin-1-yl]phenyl]azetidin-1-yl]-3-oxopropyl]-1,3-oxazolidin-2-one.

Molecular Properties

Compound Name(4R)-4-[3-[3-[4-[3-(methylsulfonylmethyl)azetidin-1-yl]phenyl]azetidin-1-yl]-3-oxopropyl]-1,3-oxazolidin-2-one
PubChem CID162745804
Molecular FormulaC20H27N3O5S
Molecular Weight421.52 g/mol
Exact Mass421.17
IUPAC Name(4R)-4-[3-[3-[4-[3-(methylsulfonylmethyl)azetidin-1-yl]phenyl]azetidin-1-yl]-3-oxopropyl]-1,3-oxazolidin-2-one
SMILESCS(=O)(=O)CC1CN(c2ccc(C3CN(C(=O)CC[C@@H]4COC(=O)N4)C3)cc2)C1
InChIInChI=1S/C20H27N3O5S/c1-29(26,27)13-14-8-22(9-14)18-5-2-15(3-6-18)16-10-23(11-16)19(24)7-4-17-12-28-20(25)21-17/h2-3,5-6,14,16-17H,4,7-13H2,1H3,(H,21,25)/t17-/m1/s1
InChIKeyXSAGVSKRGAPOAD-QGZVFWFLSA-N
XLogP0.98
TPSA96.02 Ų
H-Bond Donors1
H-Bond Acceptors6
Rotatable Bonds7
Heavy Atoms29
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500421.52
LogP ≤ 50.98
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'anil_di_alk_E(186)', 'substructure': 'N/A'}

Analyze (4R)-4-[3-[3-[4-[3-(methylsulfonylmethyl)azetidin-1-yl]phenyl]azetidin-1-yl]-3-oxopropyl]-1,3-oxazolidin-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (4R)-4-[3-[3-[4-[3-(methylsulfonylmethyl)azetidin-1-yl]phenyl]azetidin-1-yl]-3-oxopropyl]-1,3-oxazolidin-2-one?
The IUPAC name of (4R)-4-[3-[3-[4-[3-(methylsulfonylmethyl)azetidin-1-yl]phenyl]azetidin-1-yl]-3-oxopropyl]-1,3-oxazolidin-2-one (CID 162745804) is (4R)-4-[3-[3-[4-[3-(methylsulfonylmethyl)azetidin-1-yl]phenyl]azetidin-1-yl]-3-oxopropyl]-1,3-oxazolidin-2-one.
What is the SMILES notation for (4R)-4-[3-[3-[4-[3-(methylsulfonylmethyl)azetidin-1-yl]phenyl]azetidin-1-yl]-3-oxopropyl]-1,3-oxazolidin-2-one?
The canonical SMILES for (4R)-4-[3-[3-[4-[3-(methylsulfonylmethyl)azetidin-1-yl]phenyl]azetidin-1-yl]-3-oxopropyl]-1,3-oxazolidin-2-one is CS(=O)(=O)CC1CN(c2ccc(C3CN(C(=O)CC[C@@H]4COC(=O)N4)C3)cc2)C1.
What is the InChIKey of (4R)-4-[3-[3-[4-[3-(methylsulfonylmethyl)azetidin-1-yl]phenyl]azetidin-1-yl]-3-oxopropyl]-1,3-oxazolidin-2-one?
The InChIKey is XSAGVSKRGAPOAD-QGZVFWFLSA-N. The full InChI is InChI=1S/C20H27N3O5S/c1-29(26,27)13-14-8-22(9-14)18-5-2-15(3-6-18)16-10-23(11-16)19(24)7-4-17-12-28-20(25)21-17/h2-3,5-6,14,16-17H,4,7-13H2,1H3,(H,21,25)/t17-/m1/s1.
What are the key properties of (4R)-4-[3-[3-[4-[3-(methylsulfonylmethyl)azetidin-1-yl]phenyl]azetidin-1-yl]-3-oxopropyl]-1,3-oxazolidin-2-one?
(4R)-4-[3-[3-[4-[3-(methylsulfonylmethyl)azetidin-1-yl]phenyl]azetidin-1-yl]-3-oxopropyl]-1,3-oxazolidin-2-one has a molecular weight of 421.52 g/mol, XLogP of 0.98, 7 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for (4R)-4-[3-[3-[4-[3-(methylsulfonylmethyl)azetidin-1-yl]phenyl]azetidin-1-yl]-3-oxopropyl]-1,3-oxazolidin-2-one is sourced from PubChem (CID 162745804), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).